From journals and scientific sources

327 topics in this forum

1. Primary sources for data, records, papers

   By Altostrata, May 1, 2011
   • 11 replies
   • 3,030 views
   • 
   • Itzakadoozee
   • May 12

2. Important topics in Journals and Scientific Sources

   By Altostrata, May 12, 2011
   • 3 replies
   • 3,050 views
   • 
   • Altostrata
   • January 5

3. Papers about prolonged antidepressant withdrawal syndrome

   By Altostrata, May 22, 2011
   • 30 replies
   • 10,765 views
   • 
   • WiggleIt
   • November 6, 2018

4. Liver Enzymes Cytochrome P450 Drug Interaction Tables

   By Altostrata, November 17, 2011
   • 6 replies
   • 7,591 views
   • 
   • Altostrata
   • July 23, 2018

5. Official guides to tapering off psychiatric medications

   By Altostrata, December 24, 2012
   • 0 replies
   • 3,506 views
   • 
   • Altostrata
   • December 24, 2012

6. Before you start a topic in Journals....

   By Altostrata, June 29, 2012
   • 0 replies
   • 1,816 views
   • 
   • Altostrata
   • June 29, 2012

7. Read, 2019, How common and severe are six withdrawal effects from, and addiction to, antidepressants? The experiences of a large international sample of patients

   By bubbles, December 2
   • 4 replies
   • 204 views
   • 
   • bubbles
   • Thursday at 11:32 PM

8. Guidance for Psychological Therapists: Enabling conversations with clients taking or withdrawing from prescribed psychiatric drugs

   By India, Thursday at 12:12 AM
   • 0 replies
   • 96 views
   • 
   • India
   • Thursday at 12:12 AM

9. Dosage equivalent

   By Heath, Wednesday at 06:06 PM
   • 0 replies
   • 80 views
   • 
   • Heath
   • Wednesday at 06:06 PM

10. Henssler, 2019, Antidepressant Withdrawal and Rebound Phenomena

    By bubbles, November 15
    • 1 reply
    • 254 views
    • 
    • Altostrata
    • November 16

11. Stockmann, 2019 What it was like to stop an antidepressant

    By bubbles, November 6
    • 5 replies
    • 366 views
    • 
    • Valhalla
    • November 13

12. Shapiro, 2018, Subtherapeutic doses of SSRI antidepressants demonstrate considerable serotonin transporter occupancy: implications for tapering SSRIs

    By bubbles, November 12
    • 0 replies
    • 120 views
    • 
    • bubbles
    • November 12

13. Eveleigh, 2019, Patients' attitudes to discontinuing not-indicated long-term antidepressant use: barriers and facilitators

    By bubbles, November 10
    • 0 replies
    • 113 views
    • 
    • bubbles
    • November 10

14. Fluyau, 2018 Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation

    By Altostrata, November 7
    • 0 replies
    • 122 views
    • 
    • Altostrata
    • November 7

15. Davies, 2018 A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?

    By Altostrata, October 29, 2018
    • 3 replies
    • 693 views
    • 
    • Altostrata
    • October 26

16. Aydemir, 2018 SSRI Induced Apathy Syndrome

    By Altostrata, March 1
    • 6 replies
    • 678 views
    • 
    • drugged
    • September 17

17. Horowitz, 2019 Tapering of SSRI treatment to mitigate withdrawal symptoms

    By Henosis, March 6
    • 28 replies
    • 2,451 views
    • 
    • ChessieCat
    • September 2

18. Hengartner, 2019,Antidepressant withdrawal – the tide is finally turning

    By Linus, August 22
    • 1 reply
    • 330 views
    • 
    • Linus
    • August 22

19. Munkholm Munkholm, 2019, Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis

    By Linus, July 1
    • 7 replies
    • 334 views
    • 
    • Onmyway
    • July 23

20. Ruhe, 2019 Comment on Horowitz, 2019 Tapering of SSRI treatment to mitigate withdrawal symptoms

    By Onmyway, June 28   

    • lancet psychiatry
    • new tapering proposal
    • (and 1 more)

      Tagged with:

      • lancet psychiatry
      • new tapering proposal
      • horrowitz and taylor response
    • 7 replies
    • 256 views
    • 
    • kayjaydee
    • June 29

21. Papers by Dr. GA Fava, long-time critic of antidepressants

    By Altostrata, June 8, 2011
    • 10 replies
    • 8,020 views
    • 
    • Shep
    • June 28

22. Fava, 2017 The Potential Role of Iatrogenic Comorbidity in the Interaction between Pharmacotherapy and Psychotherapy in Anxiety Disorders

    By Shep, June 28
    • 0 replies
    • 135 views
    • 
    • Shep
    • June 28

23. Fava, 2019 Iatrogenic Factors in Psychopathology

    By Shep, June 25
    • 0 replies
    • 162 views
    • 
    • Shep
    • June 25

24. Baldessarini, 2019 Effects of Treatment Discontinuation in Clinical Psychopharmacology.

    By Itzakadoozee, May 12
    • 5 replies
    • 454 views
    • 
    • Itzakadoozee
    • May 21

25. Khan, 2019 Serotonin Sensitivity and Withdrawal With Low-Dose Venlafaxine

    By Altostrata, April 9
    • 0 replies
    • 489 views
    • 
    • Altostrata
    • April 9

26. Moncrieff, 2005 Rethinking models of psychotropic drug action.

    By Altostrata, April 6
    • 0 replies
    • 225 views
    • 
    • Altostrata
    • April 6

27. Récalt, 2019 Withdrawal Confounding in Randomized Controlled Trials of Antipsychotic, Antidepressant, and Stimulant Drugs, 2000-2017.

    By Altostrata, March 27
    • 0 replies
    • 234 views
    • 
    • Altostrata
    • March 27

28. Kanwaldeep, 2008 Watch for nonpsychotropics causing psychiatric side effects 1 2

    By btdt, April 23, 2014
    • 58 replies
    • 4,204 views
    • 
    • ghm2018
    • March 11

29. Veltri, 2015 Medication-induced hypokalemia

    By Altostrata, March 4
    • 0 replies
    • 124 views
    • 
    • Altostrata
    • March 4

30. Oehrberg, 1995 Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study.

    By Altostrata, January 27
    • 0 replies
    • 161 views
    • 
    • Altostrata
    • January 27

31. Andrews, 2012 Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good

    By Altostrata, April 25, 2012
    • 17 replies
    • 1,614 views
    • 
    • Altostrata
    • January 26

32. Maund, 2019 Managing Antidepressant Discontinuation: A Systematic Review.

    By Altostrata, January 26
    • 0 replies
    • 248 views
    • 
    • Altostrata
    • January 26

33. Papers about Post-SSRI Sexual Disorder (PSSD) 1 2

    By Altostrata, July 5, 2011   

    • pssd
    • sexual dysfunction
    • 36 replies
    • 17,403 views
    • 
    • Altostrata
    • January 19

34. Reisman, 2017 Sexual Consequences of Post-SSRI Syndrome.

    By Altostrata, January 19   

    • pssd
    • sexual dysfunction
    • 0 replies
    • 151 views
    • 
    • Altostrata
    • January 19

35. Bala, 2018 Post-SSRI Sexual Dysfunction: A Literature Review.

    By Altostrata, January 19   

    • pssd
    • sexual dysfunction
    • 0 replies
    • 172 views
    • 
    • Altostrata
    • January 19

36. Papp, 2018 Brain Zaps: An Underappreciated Symptom of Antidepressant Discontinuation.

    By Altostrata, January 5
    • 3 replies
    • 327 views
    • 
    • Linus
    • January 16